-DOCSTART- -X- O
Macaques -X- _ B-Patient
have -X- _ O
served -X- _ O
as -X- _ O
models -X- _ O
for -X- _ O
more -X- _ O
than -X- _ O
70 -X- _ O
human -X- _ O
infectious -X- _ O
diseases -X- _ O
of -X- _ O
diverse -X- _ O
etiologies -X- _ O
, -X- _ O
including -X- _ O
a -X- _ O
multitude -X- _ O
of -X- _ O
agentsâ€”bacteria -X- _ O
, -X- _ O
viruses -X- _ O
, -X- _ O
fungi -X- _ O
, -X- _ O
parasites -X- _ O
, -X- _ O
prions. -X- _ O
The -X- _ O
remarkable -X- _ O
diversity -X- _ O
of -X- _ O
human -X- _ O
infectious -X- _ O
diseases -X- _ O
that -X- _ O
have -X- _ O
been -X- _ O
modeled -X- _ O
in -X- _ O
the -X- _ O
macaque -X- _ O
includes -X- _ O
global -X- _ O
, -X- _ O
childhood -X- _ O
, -X- _ O
and -X- _ O
tropical -X- _ O
diseases -X- _ O
as -X- _ O
well -X- _ O
as -X- _ O
newly -X- _ O
emergent -X- _ O
, -X- _ O
sexually -X- _ O
transmitted -X- _ O
, -X- _ O
oncogenic -X- _ O
, -X- _ O
degenerative -X- _ O
neurologic -X- _ O
, -X- _ O
potential -X- _ O
bioterrorism -X- _ O
, -X- _ O
and -X- _ O
miscellaneous -X- _ O
other -X- _ O
diseases. -X- _ O
Historically -X- _ O
, -X- _ O
macaques -X- _ B-Outcome
played -X- _ I-Outcome
a -X- _ I-Outcome
major -X- _ I-Outcome
role -X- _ I-Outcome
in -X- _ I-Outcome
establishing -X- _ I-Outcome
the -X- _ I-Outcome
etiology -X- _ I-Outcome
of -X- _ I-Outcome
yellow -X- _ I-Outcome
fever -X- _ I-Outcome
, -X- _ I-Outcome
polio -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
prion -X- _ I-Outcome
diseases. -X- _ I-Outcome
With -X- _ O
rare -X- _ O
exceptions -X- _ O
( -X- _ O
Chagas -X- _ O
disease -X- _ O
, -X- _ O
bartonellosis -X- _ O
) -X- _ O
, -X- _ O
all -X- _ O
of -X- _ O
the -X- _ O
infectious -X- _ O
diseases -X- _ O
in -X- _ O
this -X- _ O
review -X- _ O
are -X- _ O
of -X- _ O
Old -X- _ O
World -X- _ O
origin. -X- _ O
Perhaps -X- _ O
most -X- _ O
surprising -X- _ O
is -X- _ O
the -X- _ O
large -X- _ B-Outcome
number -X- _ I-Outcome
of -X- _ I-Outcome
tropical -X- _ I-Outcome
( -X- _ I-Outcome
16 -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
newly -X- _ I-Outcome
emergent -X- _ I-Outcome
( -X- _ I-Outcome
7 -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
bioterrorism -X- _ I-Outcome
diseases -X- _ I-Outcome
( -X- _ I-Outcome
9 -X- _ I-Outcome
) -X- _ I-Outcome
that -X- _ I-Outcome
have -X- _ I-Outcome
been -X- _ I-Outcome
modeled -X- _ I-Outcome
in -X- _ I-Outcome
macaques. -X- _ I-Outcome
Many -X- _ O
of -X- _ O
these -X- _ O
human -X- _ O
diseases -X- _ O
( -X- _ O
e.g. -X- _ O
, -X- _ O
AIDS -X- _ O
, -X- _ O
hepatitis -X- _ O
E -X- _ O
, -X- _ O
bartonellosis -X- _ O
) -X- _ O
are -X- _ O
a -X- _ O
consequence -X- _ O
of -X- _ O
zoonotic -X- _ O
infection. -X- _ O
However -X- _ O
, -X- _ O
infectious -X- _ B-Outcome
agents -X- _ I-Outcome
of -X- _ I-Outcome
certain -X- _ I-Outcome
diseases -X- _ I-Outcome
, -X- _ I-Outcome
including -X- _ I-Outcome
measles -X- _ I-Outcome
and -X- _ I-Outcome
tuberculosis -X- _ I-Outcome
, -X- _ I-Outcome
can -X- _ I-Outcome
sometimes -X- _ I-Outcome
go -X- _ I-Outcome
both -X- _ I-Outcome
ways -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
thus -X- _ I-Outcome
several -X- _ I-Outcome
human -X- _ I-Outcome
pathogens -X- _ I-Outcome
are -X- _ I-Outcome
threats -X- _ I-Outcome
to -X- _ I-Outcome
nonhuman -X- _ I-Outcome
primates -X- _ I-Outcome
including -X- _ I-Outcome
macaques. -X- _ I-Outcome
Through -X- _ O
experimental -X- _ O
studies -X- _ O
in -X- _ O
macaques -X- _ O
, -X- _ O
researchers -X- _ O
have -X- _ O
gained -X- _ O
insight -X- _ O
into -X- _ O
pathogenic -X- _ O
mechanisms -X- _ O
and -X- _ O
novel -X- _ O
treatment -X- _ O
and -X- _ O
vaccine -X- _ O
approaches -X- _ O
for -X- _ O
many -X- _ O
human -X- _ O
infectious -X- _ O
diseases -X- _ O
, -X- _ O
most -X- _ O
notably -X- _ O
acquired -X- _ O
immunodeficiency -X- _ O
syndrome -X- _ O
( -X- _ O
AIDS -X- _ O
) -X- _ O
, -X- _ O
which -X- _ O
is -X- _ O
caused -X- _ O
by -X- _ O
infection -X- _ O
with -X- _ O
human -X- _ O
immunodeficiency -X- _ O
virus -X- _ O
( -X- _ O
HIV -X- _ O
) -X- _ O
. -X- _ O
Other -X- _ O
infectious -X- _ O
agents -X- _ O
for -X- _ O
which -X- _ O
macaques -X- _ O
have -X- _ O
been -X- _ O
a -X- _ O
uniquely -X- _ O
valuable -X- _ O
resource -X- _ O
for -X- _ O
biomedical -X- _ O
research -X- _ O
, -X- _ O
and -X- _ O
particularly -X- _ O
vaccinology -X- _ O
, -X- _ O
include -X- _ O
influenza -X- _ B-Outcome
virus -X- _ I-Outcome
, -X- _ I-Outcome
paramyxoviruses -X- _ I-Outcome
, -X- _ I-Outcome
flaviviruses -X- _ I-Outcome
, -X- _ I-Outcome
arenaviruses -X- _ I-Outcome
, -X- _ I-Outcome
hepatitis -X- _ I-Outcome
E -X- _ I-Outcome
virus -X- _ I-Outcome
, -X- _ I-Outcome
papillomavirus -X- _ I-Outcome
, -X- _ I-Outcome
smallpox -X- _ I-Outcome
virus -X- _ I-Outcome
, -X- _ O
Mycobacteria -X- _ O
, -X- _ O
Bacillus -X- _ O
anthracis -X- _ O
, -X- _ O
Helicobacter -X- _ O
pylori -X- _ O
, -X- _ O
Yersinia -X- _ O
pestis -X- _ O
, -X- _ O
and -X- _ O
Plasmodium -X- _ O
species. -X- _ O
This -X- _ O
review -X- _ O
summarizes -X- _ O
the -X- _ O
extensive -X- _ O
past -X- _ O
and -X- _ O
present -X- _ O
research -X- _ O
on -X- _ O
macaque -X- _ O
models -X- _ O
of -X- _ O
human -X- _ O
infectious -X- _ O
disease -X- _ O
. -X- _ O

